Literature DB >> 15534929

Inhibition of transfected PTEN on human colon cancer.

Shou-Shui Xu1, Wen-Lu Shen, Song-Ying Ouyang.   

Abstract

AIM: To study the inhibitory effect of transfected PTEN on LoVo cells.
METHODS: Human PTEN cDNA was transferred into LoVo cells via lipofectin and PTEN mRNA levels and its expression were analyzed by Western blot and flow cytometry. Before or after transfection, the effects of 5-Fu on inhibiting cell proliferation and inducing apoptosis were measured by flow cytometry, DNA bands and MTT.
RESULTS: PTEN transfection significantly up-regulated PTEN expression in LoVo cells. 5-Fu inhibited cell proliferation and induced apoptosis in transfected LoVo cells.
CONCLUSION: Transfected PTEN can remarkably up-regulate PTEN expression in LoVo cells and promote the apoptosis. PTEN transfection is associated with 5-Fu treatment effect and has a cooperatively cytotoxic effect.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15534929      PMCID: PMC4612015          DOI: 10.3748/wjg.v10.i24.3670

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  39 in total

1.  Colorectal carcinomas and PTEN/MMAC1 gene mutations.

Authors:  G Dicuonzo; S Angeletti; J Garcia-Foncillas; A Brugarolas; Y Okrouzhnov; D Santini; G Tonini; G Lorino; M De Cesaris; A Baldi
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

2.  The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene.

Authors:  J Li; L Simpson; M Takahashi; C Miliaresis; M P Myers; N Tonks; R Parsons
Journal:  Cancer Res       Date:  1998-12-15       Impact factor: 12.701

3.  PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy.

Authors:  Lindsey D Mayo; Jack E Dixon; Donald L Durden; Nickolas K Tonks; David B Donner
Journal:  J Biol Chem       Date:  2001-11-29       Impact factor: 5.157

4.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

5.  Regulation of constitutive expression of mouse PTEN by the 5'-untranslated region.

Authors:  Baoguang Han; Zizheng Dong; Yang Liu; Qun Chen; Katsuyuki Hashimoto; Jian-Ting Zhang
Journal:  Oncogene       Date:  2003-08-14       Impact factor: 9.867

6.  PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1.

Authors:  Aurelian Radu; Valerie Neubauer; Tsuyoshi Akagi; Hidesaburo Hanafusa; Maria-Magdalena Georgescu
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

7.  [Detection of mutation and protein expression of PTEN gene in endometrial carcinoma].

Authors:  Bing Xu; Qin Yao; Shu-Zhen Dai
Journal:  Ai Zheng       Date:  2004-01

8.  Adenovirus-mediated PTEN treatment combined with caffeine produces a synergistic therapeutic effect in colorectal cancer cells.

Authors:  Yuji Saito; Began Gopalan; Abner M Mhashilkar; Jack A Roth; Sunil Chada; Louis Zumstein; Rajagopal Ramesh
Journal:  Cancer Gene Ther       Date:  2003-11       Impact factor: 5.987

9.  In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin.

Authors:  M Tanaka; H B Grossman
Journal:  Gene Ther       Date:  2003-09       Impact factor: 5.250

10.  Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas.

Authors:  M P Davies; F E Gibbs; N Halliwell; K A Joyce; M M Roebuck; M L Rossi; J Salisbury; D R Sibson; L Tacconi; C Walker
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

View more
  1 in total

Review 1.  Crosstalk between Wnt/β-catenin and Hedgehog/Gli signaling pathways in colon cancer and implications for therapy.

Authors:  Li Song; Zhuo-Yu Li; Wei-Ping Liu; Mei-Rong Zhao
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.